?hepatocellular

hepatocellular發(fā)音

英：[hep?t??'selj?l?]　　美：[hep?to?'selj?l?]

英：　　美：

hepatocellular中文意思翻譯

adj. 肝細胞的

hepatocellular常見(jiàn)例句

1 、In the US the incidence of variceal hemorrhage seems to be declining， while the incidence of hepatocellular carcinoma seems to be increasing.───在美國，靜脈曲張出血發(fā)生率似乎在下降，而肝細胞癌發(fā)生率似乎在升高。

2 、Objective To explore postresective prognosis for hepatocellular carcinoma of caudate lobe.───摘要目的探討尾葉肝癌切除術(shù)的預后。

3 、HCC(hepatocellular carcinoma) poses a significant disease burden in many parts of the world.───在世界各地，HCC（肝細胞肝癌）成為了嚴重的疾病負擔。

4 、Infection with hepatitis C virus (HCV) can cause chronic hepatitis, cirrhosis, and even hepatocellular carcinoma (HCC).───摘要丙型肝炎病毒的感染會(huì )引起慢性肝炎、肝硬化、甚至肝癌。

5 、Methods The expression of OPN was detected by immunohistochemistry in 34 hepatocellular carcinomas and 14 para-tumorous tissues.───方法應用免疫組織化學(xué)法檢測34例肝癌和14例癌旁組織中OPN的表達；

6 、Among 6 cases of MRI,4 were diagnosed as adrenal pheochromocytoma,and 2 were misdiagnosed as hepatocellular carcinoma.───6例中，4例疑診嗜鉻細胞瘤，2例診斷為巨塊型肝癌。

7 、Objective To evaluate the effects of dense endoscopic variceal ligation (DEVL) for bleeding varices with primary hepatocellular carcinoma(PHC).───方法采用內鏡下密集多點(diǎn)結扎術(shù)治療原發(fā)性肝癌合并食管靜脈曲張急性出血患者58例。

8 、Perforin and Fas-ligand expression of tumor infiltrating lymphocytes in human hepatocellular carcinoma Qian Qijun, Wu Mengchao, Qu zengqiang, et al.───中華病理學(xué)雜志1998年第2期第0卷作者：錢(qián)其軍吳孟超曲增強方石崗王華菁曹惠芳賈隨旺郭亞軍關(guān)鍵詞：肝腫瘤；淋巴細胞，腫瘤浸潤；配體；穿孔素...

9 、Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in humans.───摘要肝細胞癌是人類(lèi)最常見(jiàn)的癌癥。

10 、Hepatocellular damage was the dominant type of DILD (66.1%, 41/62) and severe liver function damage or acute liver failure was rare.───臨床類(lèi)型主要為肝細胞型(41/62，66.1%)，重癥或爆發(fā)性少見(jiàn)；

11 、Hepatitis B virus (HBV) is an important aetiological factor in the development of hepatocellular carcinoma , especially in Asian countries.───乙型肝炎病毒（HBV）感染是亞洲地區肝癌患者最常見(jiàn)的致病因素[1,2]。

12 、KLF6 gene suppresses hepatocellular carcinoma cell proliferation,which may be partially associated with the upregulation of p21(WAF1) expression.───KLF6基因表達水平的下降可能在原發(fā)性肝癌發(fā)病機制中起到一定作用。 上調p21WAF1表達是KLF6基因抑制肝癌細胞增殖的重要途徑.

13 、Rates of de novo malignancies and recurrent hepatocellular carcinoma were identical.───新發(fā)惡性腫瘤及肝細胞癌復發(fā)率相同。

14 、Objective To study the integration of HBV on hepatocellular chromosome of the patients with chronic hepatitis B.───摘要目的研究慢性乙型肝炎患者肝細胞染色體是否存在HBV的整合及整合情況。

15 、Objective To evaluate the effect of selenomethionine (SeMet) on the apoptosis of hepatocellular Carcinoma cell line SMMC7402 and explore its mechanism.───摘要目的：研究硒蛋氨酸對肝癌細胞株SMMC7402生長(cháng)的影響及其作用機制。

16 、Transcatheter arterial chemoembolization (TACE) is widely used to treat non-resectable hepatocellular carcinoma (HCC).───摘要動(dòng)脈化學(xué)栓塞療法，已被廣泛用在治療無(wú)法作開(kāi)刀手術(shù)治療之肝癌病人。

17 、Methods The specimens were divided into tumor group,group of tissue adjacent to tumor,human hepatocellular carcinoma group (n=10 in each group).───方法標本分為腫瘤組,癌旁組,人肝癌組(每組數n=10)。

18 、Objective To evaluate therapeutic efficacy of segmental transcatheter hepatic arterial chemoembolization (segmental TACE) for hepatocellular carcinoma.───摘要目的：探討肝節段動(dòng)脈栓塞化療治療肝癌的療效。

19 、The hepatocellular carcinoma is considered as one of the suitable targets for anti-angiogenic approaches due to its highly neovascularization.───摘要:肝細胞癌通常有會(huì )較多血管異常增生的現象，所以很適合使用抗血管新生療法治療。

20 、In this article, we present a rare case of sclerosing hepatocellular carcinoma with emphasis on imaging diagnosis with a review of the literature.───在本文中我們報告一罕見(jiàn)之硬化型肝癌，除著(zhù)重在影像學(xué)所見(jiàn)外并作文獻之回顧。

21 、Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.───放射介入栓塞化療對肝癌合并門(mén)靜脈癌栓治療的療效觀(guān)察。

22 、Patients cycled between the following health states: viral suppression, ongoing viremia, seroconversion, hepatocellular carcinoma, cirrhosis and death.───**患者經(jīng)歷以下的疾病狀態(tài)：病毒抑制、病毒血癥期、血清轉化、肝細胞癌、肝硬化和死亡。

23 、Hepatocellular carcinoma and/or decompensation was diagnosed in 33 (25%), after a median interval of 41months.───另外，還有33人(占25%)診斷為肝細胞性肝癌和（或）肝炎后肝硬化失代償期,中位生存期41個(gè)月。

24 、Mutations of Axin have been identified previously in cerebellar medulloblastomas, hepatocellular carcinomas, brest carcinoma and hepatoblastomas.───已經(jīng)在人髓母細胞瘤、肝細胞肝癌、肝母細胞瘤及乳腺癌中檢測到了Axin基因的突變。

25 、Regionally, these infections usually accounted for more than 50% of hepatocellular carcinoma and cirrhosis cases.───地區性的，這些感染通常占據50%以上的肝細胞癌和肝硬化病例。

26 、One of the two had hepatocellular carcinoma and died of hepatic failure at week 125; the other received adefovir dipivoxil (Hepsera) and is doing well.───兩名中一位因為癌變在125周的時(shí)候肝臟衰竭死亡;另外一位接受阿迪治療,表現良好.

27 、To investigate the expression and role of RTN in the oncogenessis of human hepatocellular carcinoma(HCC).───為研究肝癌中內質(zhì)網(wǎng)蛋白基因(RTN)表達及初步功能。

28 、Hepatocellular carcinoma (HCC) usually metastasizes to lung, adrenal gland, bone, and lymph nodes, while cutaneous metastasis from HCC is a rare event.───摘要肝細胞癌常轉移至肺、腎上腺、骨頭與淋巴結，而表皮轉移極為罕見(jiàn)。

29 、Abstract： Objective To investigate the possibility and the safety of resecting large hepatocellular carcinoma.───摘 要： 目的 探討手術(shù)切除大肝癌的可行性和安全性。

30 、Methods:5 small hepatocellular carcinomas(HCCs) and 3 hepatic metastatic carcinomas(HMCs) were performed chemo ablation of PAI under the CT guidance.───方法:5例小肝癌、3例肝轉移癌在CT引導下經(jīng)皮乙酸注射化學(xué)滅活術(shù)。

31 、A 77-year-old man, who had undergone TACE and hepatic surgery for hepatocellular carcinoma twice, was admitted due to biliptysis and dyspnea.───一位因肝癌而曾經(jīng)接受過(guò)兩次局部肝切除手術(shù)和動(dòng)脈導管化學(xué)栓塞的七十七歲男**人，因為氣促以及咳嗽中帶有膽汁而住院接受治療。

32 、XU Ke-cheng, NIU Li-zhi, HU Yi-zhe, et al. PERCUTANEOUS CRYOABLATION IN COMBINATION WITH ETHANOL INJECTION FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA.───徐克成、牛立志、胡以則,等。經(jīng)皮冷消融聯(lián)合酒精注射治療不能切除的肝細胞癌。

33 、Liu HY.Hepatitis C viral antigen and hepatocellular carcinoma [J ].Chin Dig J, 1996, 16(2): 65.───[1]劉厚鈺.丙型肝炎病毒與原發(fā)性肝癌[J].中華消化雜志,1996,16(2):65.

34 、Hepatic infarction is a rare complication of radiofrequency ablation (RFA) for hepatocellular carcinoma.───摘要肝臟梗塞是肝癌射頻燒灼術(shù)所造成的少見(jiàn)并發(fā)癥之一。

35 、Methods There were 52 patients including 26 with primary hepatocellular carcinoma and 26 with liver cirrhotic nodules.───方法選取52例患者，其中原發(fā)性肝細胞癌26例，肝硬化結節26例。

36 、We report a rare, hyperkeratotic form of porokeratosis of Mibelli in a patient with hepatocellular cell carcinoma, hepatitis B and recurrent hypoglycemia.───我們報告一位患有肝細胞癌、B型肝炎以及反覆性低血糖的病人，身上同時(shí)有罕見(jiàn)的過(guò)度角化型米貝利汗孔角化癥的皮膚病變。

37 、Hepatocellular injury was common. Renal involved in severe cases. mortality rate of AHS was 14.3%(1/7).───全部病例均有發(fā)熱、皮疹、白細胞增多、嗜酸粒細胞增多、血清肌酶升高 ,常伴有肝損害 ,嚴重者有腎臟受累 ,死亡率 14 .3%(1/7)。

38 、ABSTRACT Objective To evaluate the severe complications of transcatherter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).───摘要 目的 評價(jià)經(jīng)導管肝動(dòng)脈化療栓塞術(shù)（TACE）治療肝細胞癌（HCC）的嚴重并發(fā)癥。

39 、There was a good time and dose effect dependent manner and Bel 7402 hepatocellular carcinoma cells were inhibited by HAP nanopaticles.───HAP納米粒子在體外對人肝癌細胞系Bel 74 0 2具有明顯的抑制作用 ,并呈現良好的量效和時(shí)效關(guān)系。

40 、While primary hepatic carcinoma is common in Asia, hepatocellular carcinoma (HCC) combined with cholangiocellular carcinoma (CCC) is rare.───摘要原發(fā)性肝惡性腫瘤是亞洲常見(jiàn)疾病但合并膽管癌與肝細胞癌是其中少見(jiàn)之型式。

41 、ASAC and Zn2+ caused a time-dependent inhibition of survival and growth in human hepatocellular carcinoma SMMC-7721 cells.───ASAC和Zn~(2+)聯(lián)合對人肝癌細胞SMMC-7721生長(cháng)的抑制作用，具有時(shí)間依賴(lài)性，并不具有濃度依賴(lài)性。

42 、The mortality rates of UGI bleeding in patients with hepatocellular carcinoma (HCC) associated with portal hypertension were 63%.───合并肝癌患者上消化道出血之死亡率則為63%。

43 、Regionally, these infections usually accounted for more than50% of hepatocellular carcinoma and cirrhosis cases.───地區性的，這些感染通常占據50%上的肝細胞癌和肝硬化病例。

44 、Abstract: Object To study the inhibitory effects of vitamin K2 on invasion and metastasis ability of hepatocellular carcinoma cells.───摘要目的研究維生素K2對人肝癌細胞的體外抗黏附、抗侵襲轉移及生長(cháng)抑制作用。

45 、Of this percentage, hepatocellular carcinoma was caused by Hep B in 53%, and Hep C in 25%.───在這個(gè)百分比中，**造成的肝細胞癌是53%，丙肝是25%。

46 、Materials and Methods: Ten cirrhotic patients (group A) underwent minor liver resections due to hepatocellular carcinoma (HCC).───方法和材料：10個(gè)肝硬化患者（A組）因為肝細胞癌行肝次全切。

47 、Methods:The hepatic dual phase helical CT scanning of 7 cases of pedunculated hepatocellular carcinoma were reviewed retrospectively.───方法:回顧性分析了7例外生性肝癌螺旋CT肝雙期掃描的CT表現。

48 、Objective To explore the protective function of Tiopronin on side effects in patients with hepatocellular carcinoma after interventional therapy.───摘要目的探討硫普羅寧（商品名凱西萊）對肝癌介入治療后不良反應的防治作用。

49 、Objective: To search for the biomarkers for differential diagnosis between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).───摘要目的：分析肝細胞癌和肝內膽管癌蛋白質(zhì)的表達差異，獲取鑒別兩者的分子標志物。

50 、Chiappa A，Zbar A，Audisio RA，et al.Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis[J].───劉嘉林，李軍，鮑世韻，等.急診肝動(dòng)脈栓塞治療原發(fā)性肝癌自發(fā)破裂出血（附38例報告）[J].中國普外基礎與臨床雜志，2003，10（3）:276-277.

51 、It is suggested that the indomethacin might improve the NK activity of the patients with advanced hepatocellular carcinoma.───提示消炎痛能增強中晚期原發(fā)性肝癌NK細胞的活性。

52 、Primary liver cell carcinoma(PLCC)or Hepatocellular carcinoma(HCC)is the most common primary malignant liver tumor in ...───醫療事故 防范與糾紛班.IOF亞洲骨質(zhì)疏松班. 中西醫結合骨科診療班. 全 ...

53 、Objective To evaluate the value of transcatheter arterial embalization (TAE) in spontaneous rupture of hepatocellular carcinoma (HCC).───摘要目的評價(jià)經(jīng)導管動(dòng)脈栓塞(TAE)搶救肝細胞性肝癌(HCC)自發(fā)性破裂出血的方法及效果。

54 、Hepatitis B may increase the chances of liver damage (cirrhosis) and hepatocellular carcinoma (HCC) that may eventually lead to death.───乙型肝炎病情遷延，難以治愈，有相當多部分病人發(fā)展為肝硬化和肝癌以致死亡。

55 、Objective To study whether the melatonin (MT) can attenuate hepatocellular injury caused by ischemia-reperfusion(I/R) injury in rat liver.───摘要目的利用大鼠肝臟熱缺血再灌注(I/R)損傷模型，研究褪黑素(MT)對再灌注損傷肝臟的保護作用。

56 、Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance.───一氧化氮合酶在原發(fā)性肝癌及癌旁肝硬化組織中的表達及其意義。

57 、Zheng XY, Lin ZY, et al. The abundance of nmH mRNA is related with in situ microenvironment and intrahepatic metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res ,():-.───任正剛.林芷英等.原發(fā)性肝癌切除術(shù)后早期行肝動(dòng)脈造影和肝動(dòng)脈栓塞化療發(fā)現和治療殘癌的價(jià)值.中國臨床醫學(xué)雜志,:.

58 、Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas （HCC） and germ cell neoplasms, especially yolk sac tumors.───主要用于檢測肝細胞癌、生殖細胞腫瘤，尤其是卵黃囊腫瘤。

59 、HAb18 Fab was prepared successfully, which lays a foundation for its further application to diagnosis and therapy of human hepatocellular carcinoma.───成功地構建了抗人肝癌小分子Fab抗體,為其進(jìn)一步在肝癌診斷與治療中的應用奠定了基礎。

60 、GOI of IGF2 may take part in human hepatocellular carcinogenesis.───IGF2基因印跡的重新獲得可能參與了肝癌的發(fā)生

61 、Hepatocellular carcinoma is a typical hypervascular tumor and intratumor MVD is an important prognostic factor for HCC patients.───前言 肝細胞癌（Hepatocellular Carcinoma, HCC）是典型的多血管腫瘤，腫瘤微血管密度（microvessel density，MVD）是肝癌重要的預后指標。

62 、Early diagnosis of primary hepatocellular carcinoma.───原發(fā)性肝癌的早期診斷。

63 、Objective: To study the expressions of osteopontin (OPN) in hepatocellular carcinoma (HCC) and angiogenesis.───摘要目的探討骨橋蛋白(OPN)在肝細胞癌（肝癌）組織中的表達與血管生成的關(guān)系。

64 、Objective: To study the way of diagnosis and interventional treatment of extrahepatic growing hepatocellular carcinoma.───摘要目的：研究外生型肝癌的診斷及介入治療的方法。

65 、Methods We analyzed the features, reasons for misdiagnoses and therapeutic principles of extrahepatic growing hepatocellular carcinoma in 8 cases.───方法分析8例外生型肝癌的特點(diǎn)、誤診原因、處理原則。

66 、Better survival in female patients with hepatocellular carcinoma: Oral contraceptive pills related?───女性肝細胞癌存活率較高:與口服**藥有關(guān)?

67 、Abstract: Objective To study the relationship of CD44V6 and PCNA expressionwith tumor thrombus forming in human hepatocellular carcinima (HCC).───文摘:目的主要探討人肝細胞癌中靜脈栓形成與CD44V6和PCNA表達的關(guān)系。

68 、Key words: Vitamin K2；invasion；metastasis；hepatocellular carcinoma cells.───關(guān)鍵詞：維生素K2；肝癌；侵襲；轉移；生長(cháng)抑制。

69 、Objective To evaluate the clinical efficacy of transcatheter hepatic artery chemoembolization for treat acute rupture to hepatocellular carcinoma.───摘要目的評價(jià)急診肝動(dòng)脈化療栓塞術(shù)治療肝癌破裂出血的療效。

70 、Sclerosing (or scirrhous) hepatocellular carcinoma is a subtype of hepatocellular carcinoma.───摘要硬化型肝癌是一少見(jiàn)之肝癌亞型。

71 、In 49 patients associated with hepatocellular carcinoma, 90% of them bled from EGV.───49位合并有肝癌之患者，90%出血部位是源于食道靜脈瘤。

72 、Can the Degree of Malignancy of Hepatocellular Carcinoma Be Indicated by CDFI?───彩色多普勒血流顯像能預示肝癌的惡性程度嗎?

73 、We’re not yet at the point where we can treat with an antifibrotic, reduce the scar, and decrease the incidence of hepatocellular carcinoma.───我們現在還達不到抗纖維化治療、減少瘢痕、降低肝細胞癌發(fā)生率的程度。

74 、Progresses in detecting small hepatocellular carcinoma with digital subtraction angiography, CT and MRI.───小肝癌的數字減影血管造影、計算機X線(xiàn)體層掃描和磁共振成像診斷進(jìn)展

75 、Objective: To discuss the character and value of CT perfusion imaging in primary hepatocellular carcinoma with multislice helical CT.───摘要目的：探討肝癌內部CT灌注特點(diǎn)及CT灌注成像在肝癌診治中的應用價(jià)值。

76 、A bilateral orchiectomy was performed, and pathology examination demonstrated hepatocellular carcinoma metastatic to the left testis.───患者接受了雙側睪丸切除手術(shù)，組織病理檢查發(fā)現左側睪丸腫瘤是由肝癌轉移而來(lái)。

77 、We reported an occurrence of hemocholecyst in a patient 6 months after undergoing radiofrequency ablation for hepatocellular carcinoma (HCC).───我們報告一例病患于肝癌射頻燒灼術(shù)后六個(gè)月發(fā)生的膽囊出血。

78 、P-selectin and CD15 may be involved in progression of hepatocellular carcinoma and can serve as potential targets for tumor therapy.───P-selectin、CD15與肝細胞癌侵襲轉移關(guān)系密切,可能成為腫瘤治療的理想靶分子。

79 、Abstract： Surgery excision is still the main treatment method for primary hepatocellular carcinoma (PHC),but the exairesis scope is pending.───摘要： 手術(shù)切除是原發(fā)性肝癌的主要治療手段之一，對手術(shù)切除的范圍，目前尚無(wú)定論。

80 、Prevention and treatment of pleural effusion after partial right hepatectomy of hepatocellular carcinoma.───右肝癌切除術(shù)后胸腔積液的防治。

肝硬化會(huì )導致肝癌嗎？

肝硬化是肝癌的鐵定危險因素?？梢赃@么說(shuō)，無(wú)論哪種原因的慢性肝病，只要發(fā)展到了肝硬化，就都有發(fā)生肝癌的可能性了。

有很多肝病，比如**，導致肝病的**病毒本身就有致癌性。這種情況下，即使沒(méi)有肝硬化，病人也可能會(huì )得肝癌。

但肥胖引起的脂肪肝，酒精性肝病這些慢性肝病本身不會(huì )導致肝癌，如果在還沒(méi)有發(fā)生肝硬化的時(shí)候，就能把這些肝病治好了，人就不會(huì )得肝癌了。

肝硬化病人之所以容易得肝癌，是因為肝硬化的時(shí)候，肝臟里面的結構將發(fā)生很多改變，而與致癌性最為密切的變化就是肝細胞周?chē)难茉絹?lái)越少；從而導致肝細胞缺血缺氧，讓肝細胞不斷壞死和增生。在肝細胞的過(guò)度增生過(guò)程中，就會(huì )有各種基因突變發(fā)生，如果與致癌性相關(guān)的基因發(fā)生了變化，病人就會(huì )得肝癌了。

因此，盡量避免肝硬化的發(fā)生，是減少肝癌風(fēng)險的有效措施。這也是我們肝病醫生治療各種慢性肝病的最終目標。

肝硬化會(huì )導致肝癌嗎？

對于肝硬化患者而言，心中總有一個(gè)憂(yōu)慮，就是肝硬化會(huì )不會(huì )在某天發(fā)展為肝癌。根據數據顯示，百分之八十五到九十的肝硬化患者病情能夠得到很好的控制，肝細胞最終沒(méi)有發(fā)生癌變。肝硬化與肝癌有著(zhù)密不可分的聯(lián)系，但不是所有肝硬化到晚期都會(huì )發(fā)展成為肝癌。

肝硬化是一種慢性疾病，離肝癌還有很長(cháng)距離。在我國，病毒性肝炎引發(fā)的肝硬化占多數可能，當然還有酒精性，遺傳代謝性，工業(yè)毒物等可能。對于**患者而言，要重視自己肝臟功能是否過(guò)快退化，不要發(fā)展成肝硬化再追悔莫及。

肝臟逐漸變得纖維化的過(guò)程就是我們常說(shuō)的肝硬化，早期患者會(huì )出現食欲不振，消化不良，全身疲倦等癥狀。及時(shí)就診，通過(guò)藥物或者手術(shù)治療，大部分患者的病情都能有所緩解。后續還要調整飲食結構與生活習慣，定期復診，檢查肝功能等，才能保持身體在一個(gè)較好的狀態(tài)，避免晚期癌變。

肝硬化患者要重視休息，保證每天的睡眠時(shí)間，避免過(guò)度疲勞，合理作息，不要熬夜。在飲食中，減少脂肪含量過(guò)高的食物的攝入，加強身體鍛煉，控制自己的體重，避免脂肪肝的出現。多吃維生素豐富的綠色蔬菜與應季水果，這對預防癌癥有一定的作用。戒除煙酒對于肝硬化患者而言也是必不可少的，相關(guān)研究表明煙酒能大大提高癌癥出現的概率。

喜歡這個(gè)回答，請點(diǎn)贊或推薦給朋友。收獲更多靠譜的肝膽相關(guān)知識，關(guān)注肝膽外科醫生劉波